Celyad Oncology SA
Celyad Oncology SA
07/28/2026 | Press release | Distributed by Public on 07/28/2026 12:33
Publication of a transparency notification received from Tolefi SA (Article 14§1 of the Law of 2 May 2007)
Mont-Saint-Guibert, Belgium; July 28, 2026, 08:30 pm CET; regulated information - Celyad Oncology (Euronext: CYAD) (the "Company" or "Celyad Oncology"), today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major shareholdings in issuers whose securities are admitted to trading on a regulated market (the "Transparency Law"), that it received a transparency notification dated July 24, 2026, from Tolefi SA and related persons indicating that they have jointly crossed passively below the 10% threshold, holding 6,568,978 shares, or 8.77% of the voting rights of the Company as of July 16, 2026.
Content of the Notification:
- Reason of the notification:
- Passive crossing of threshold
- Notification by:
- Persons acting in concert
- Persons subject to the notification requirement:
- Tolefi SA, Chaussée de Waterloo 1589D, 1180 Brussels
- Serge Goblet
- Isabelle Thoumyre
- Jérôme Goblet
- Jean-Daniel Goblet
- Date on which the threshold is crossed:
- July 16, 2026
- Threshold that is crossed (in %):
- 10
- Denominator:
- 74,883,166
- Notified details:
| Voting Rights | Previous notification | After the transaction | |||
| # of voting rights | # of voting rights | % of voting rights | |||
| Holders of voting rights | Linked to the securities | Not linked to the securities | Linked to the securities | Not linked to the securities | |
| Serge GOBLET | 56,180 | 56,180 | 0 | 0.08% | 0.00% |
| Isabelle THOUMYRE | 7,300 | 7,300 | 0 | 0.01% | 0.00% |
| Tolefi SA | 6,504,864 | 6,504,864 | 0 | 8.69% | 0.00% |
| Subtotal | 6,568,344 | 6,568,344 | 0 | 8.77% | 0.00% |
| Jérôme GOBLET | 250 | 250 | 0 | 0.00% | 0.00% |
| Jean-Daniel GOBLET | 384 | 384 | 0 | 0.00% | 0.00% |
| TOTAL | 6,568,978 | 0 | 8.77% | 0.00% | |
| Equivalent financial instruments | After the transaction | |||||
| Holders of equivalent financial instruments | Type of financial instrument | Expiration date | Exercise period or date | # of voting rights that may be acquired if the instrument is exercised | % of voting rights | settlement |
| TOTAL | 0 | 0.00% | ||||
| Total (A&B) | # of voting rights | % of voting rights |
| 6,568,978 | 8.77% |
- Full chain of controlled undertakings through which the holding is effectively held:
- Tolefi SA is controlled by Mr. Serge Goblet and Mrs. Isabelle Thoumyre, according to articles 1:14-1.18 of the Code of companies and associations
Miscellaneous:
- The Press Release may be consulted on the website of Celyad Oncology:
- https://celyad.com/newsroom
- The notification can be consulted on the website of Celyad Oncology:
- https://celyad.com/investors/regulated-information/
- Contact person(s):
- Any transparency notification must be sent to our Company by email to the attention of Hannes Iserentant, General Manager: [email protected]
Celyad Oncology SA published this content on July 28, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on July 28, 2026 at 18:33 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]